Metraipolis › archive › dc_ec7cacffa59f
Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes — Europe PMC PMID:41178701
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41178701
- DOI
- 10.1111/dom.70267
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:56:21.884Z
- SHA-256 of the archived text
6c680724898479dd530397f7ad92447c88373af1ec2f59ddd00bcf28075950ea- Stable URL of this page
https://metraipolis.com/documento/dc_ec7cacffa59f
How to cite
Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes — Europe PMC PMID:41178701 — Europe PMC (en), https://europepmc.org/article/MED/41178701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec7cacffa59f (Metraipolis archive dc_ec7cacffa59f, sha256 6c680724898479dd530397f7ad92447c88373af1ec2f59ddd00bcf28075950ea)
BibTeX
@misc{dcec7cacffa59f,
title = {Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes — Europe PMC PMID:41178701},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41178701},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec7cacffa59f; sha256 6c680724898479dd530397f7ad92447c88373af1ec2f59ddd00bcf28075950ea},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41178701. Agents can read the archived copy with the MCP tool read_document.